In Vivo Screening Data Summary

NCI In Vivo Screening Data

Mammary Adenocarcinoma CD8F1 (subcutaneous) in CD8F1

NSC 291305
CAS 1197-18-8
Tranexamic acid; DV79; DV 79

Chemical Data
Schedule (route) Endpoint Vehicle Dose Treated/Control (%) Observations
Q01DX001 (ip) median tumor weight change saline with Tween-80 125.0 mg/kg/injection 63.0 Antitumor endpoint evaluated on day 39; 10/10 animals surviving on day 39
Q01DX001 (ip) median tumor weight change saline with Tween-80 250.0 mg/kg/injection 86.0 Antitumor endpoint evaluated on day 39; 10/10 animals surviving on day 39
Q01DX001 (ip) median tumor weight change saline with Tween-80 500.0 mg/kg/injection 36.0 Antitumor endpoint evaluated on day 39; 10/10 animals surviving on day 39
Q01DX001 (ip) median tumor weight change saline with Tween-80 1000.0 mg/kg/injection 97.0 Antitumor endpoint evaluated on day 39; 10/10 animals surviving on day 39
Q01DX001 (ip) median tumor weight change saline with Tween-80 2000.0 mg/kg/injection 62.0 Antitumor endpoint evaluated on day 39; 10/10 animals surviving on day 39